Posted inBiotechnology
Posted inBiotechnology
Cemiplimab and fianlimab with neoadjuvant chemotherapy in early-stage high-risk -negative breast cancer
About the Study: Is combined inhibition of programmed cell death 1 protein (PD-1) and lymphocyte activation gene 3 (LAG-3) added…








